Anna Syreeni

8PUBLICATIONS
36CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)NeurogeneticsMajor global burdens of diseaseCardiovascular medicine and haematology not elsewhere classifiedGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 22, 2026
Blood DNA methylation markers are associated with diabetic kidney disease progression in type 1 diabetes.

Anna Syreeni, Emma H Dahlström, Laura J Smyth

|Dec 09, 2024
Blood methylation biomarkers are associated with diabetic kidney disease progression in type 1 diabetes.

Anna Syreeni, Emma H Dahlström, Laura J Smyth

|May 22, 2024
Integrated analysis of blood DNA methylation, genetic variants, circulating proteins, microRNAs, and kidney failure in type 1 diabetes.

Zhuo Chen, Eiichiro Satake, Marcus G Pezzolesi

|Dec 22, 2022
Epigenome-wide meta-analysis identifies DNA methylation biomarkers associated with diabetic kidney disease.

Laura J Smyth, Emma H Dahlström, Anna Syreeni

|Nov 21, 2022
Haptoglobin Genotype Does Not Confer a Risk of Stroke in Type 1 Diabetes.

Anna Syreeni, Emma H Dahlström, Stefanie Hägg-Holmberg

Pageof 2